Literature DB >> 11876763

Characterization of Herpesvirus saimiri-transformed T lymphocytes from common variable immunodeficiency patients.

J A Cabanillas1, R Cambronero, A Pacheco-Castro, M C García-Rodríguez, J M Martín-Fernández, G Fontán, J R Regueiro.   

Abstract

Common variable immunodeficiency (CVID) is a very frequent but heterogeneous syndrome of antibody formation. The primary defect remains unknown, but many reports describe peripheral blood T lymphocyte dysfunctions in a substantial proportion of CVID patients, which may impair T--B cell collaboration. In order to investigate whether such putative defects were intrinsic to T cells or, rather, secondary to quantitative differences in T cell subset distribution, or to other described disorders, we have used Herpesvirus saimiri (HVS) for the targeted transformation of CVID CD4+ and CD8+ T cells and subsequent functional evaluation by flow cytometry of their capacity to generate cell surface (CD154, CD69) or soluble (IL-2, TNF-alpha, IFN-gamma) help after CD3 engagement. Unexpectedly, the results showed that 40 different CVID blood samples exposed to HVS gave rise with a significantly increased frequency to transformed CD4+ T cell lines, compared to 40 age-matched controls (27% versus 3%, P < or = 0.00002) suggesting the existence of a CVID-specific signalling difference which affects CD4+ cell transformation efficiency. The functional analysis of 10 CD4+ and 15 CD8+ pure transformed T cell lines from CVID patients did not reveal any statistically significant difference as compared to controls. However, half of the CD4+ transformed cell lines showed CD154 (but not CD69) induction (mean value of 46.8%) under the lower limit of the normal controls (mean value of 82.4%, P < or = 0.0001). Exactly the same five cell lines showed, in addition, a significantly low induction of IL-2 (P < or = 0.04), but not of TNF-alpha or IFN-gamma. None of these differences were observed in the remaining CD4+ cell lines or in any of the transformed CD8+ cell lines. We conclude that certain CVID patients show selective and intrinsic impairments for the generation of cell surface and soluble help by CD4+ T cells, which may be relevant for B lymphocyte function. The transformed T cell lines will be useful to establish the biochemical mechanisms responsible for the described impairments.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11876763      PMCID: PMC1906345          DOI: 10.1046/j.1365-2249.2002.01716.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  29 in total

1.  Up-regulation of IL-12 in monocytes: a fundamental defect in common variable immunodeficiency.

Authors:  R Cambronero; W A Sewell; M E North; A D Webster; J Farrant
Journal:  J Immunol       Date:  2000-01-01       Impact factor: 5.422

2.  Fine mapping of IGAD1 in IgA deficiency and common variable immunodeficiency: identification and characterization of haplotypes shared by affected members of 101 multiple-case families.

Authors:  I Vorechovský; M Cullen; M Carrington; L Hammarström; A D Webster
Journal:  J Immunol       Date:  2000-04-15       Impact factor: 5.422

Review 3.  Selective IgA deficiency (SIgAD) and common variable immunodeficiency (CVID).

Authors:  L Hammarström; I Vorechovsky; D Webster
Journal:  Clin Exp Immunol       Date:  2000-05       Impact factor: 4.330

4.  Enhanced apoptosis of T cells in common variable immunodeficiency (CVID): role of defective CD28 co-stimulation.

Authors:  M Di Renzo; Z Zhou; I George; K Becker; C Cunningham-Rundles
Journal:  Clin Exp Immunol       Date:  2000-06       Impact factor: 4.330

5.  Membrane and transmembrane signaling in Herpesvirus saimiri-transformed human CD4(+) and CD8(+) T lymphocytes is ATM-independent.

Authors:  M Rivero-Carmena; O Porras; B Pelaez; A Pacheco-Castro; R A Gatti; J R Regueiro
Journal:  Int Immunol       Date:  2000-06       Impact factor: 4.823

6.  Diagnosis of X-linked lymphoproliferative disease by analysis of SLAM-associated protein expression.

Authors:  K C Gilmour; T Cranston; A Jones; E G Davies; D Goldblatt; A Thrasher; C Kinnon; K E Nichols; H B Gaspar
Journal:  Eur J Immunol       Date:  2000-06       Impact factor: 5.532

7.  Study of the B cell memory compartment in common variable immunodeficiency.

Authors:  J C Brouet; A Chedeville; J P Fermand; B Royer
Journal:  Eur J Immunol       Date:  2000-09       Impact factor: 5.532

8.  Impaired up-regulation of CD86 in B cells of "type A" common variable immunodeficiency patients.

Authors:  A Denz; H Eibel; H Illges; G Kienzle; M Schlesier; H H Peter
Journal:  Eur J Immunol       Date:  2000-04       Impact factor: 5.532

9.  Defects in antigen-driven lymphocyte responses in common variable immunodeficiency (CVID) are due to a reduction in the number of antigen-specific CD4+ T cells.

Authors:  M Funauchi; J Farrant; C Moreno; A D Webster
Journal:  Clin Exp Immunol       Date:  1995-07       Impact factor: 4.330

10.  Defective recruitment and activation of ZAP-70 in common variable immunodeficiency patients with T cell defects.

Authors:  M Boncristiano; M B Majolini; M M D'Elios; S Pacini; S Valensin; C Ulivieri; A Amedei; B Falini; G Del Prete; J L Telford; C T Baldari
Journal:  Eur J Immunol       Date:  2000-09       Impact factor: 5.532

View more
  3 in total

1.  Herpesvirus saimiri STP-A oncoprotein utilizes Src family protein tyrosine kinase and tumor necrosis factor receptor-associated factors to elicit cellular signal transduction.

Authors:  Maria I Garcia; Joseph Kaserman; Young-Hwa Chung; Jae U Jung; Sun-Hwa Lee
Journal:  J Virol       Date:  2006-12-20       Impact factor: 5.103

2.  Modulation of T-cell receptor signal transduction by herpesvirus signaling adaptor protein.

Authors:  Sun-Hwa Lee; Young-Hwa Chung; Nam-Hyuk Cho; Yousang Gwack; Pinghui Feng; Jae U Jung
Journal:  Mol Cell Biol       Date:  2004-06       Impact factor: 4.272

Review 3.  Virus-Encoded Complement Regulators: Current Status.

Authors:  Anwesha Sinha; Anup Kumar Singh; Trupti Satish Kadni; Jayati Mullick; Arvind Sahu
Journal:  Viruses       Date:  2021-01-29       Impact factor: 5.048

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.